(IUSV) Core S&P U.S. Value - Overview
Etf: Large-Cap Stocks, Value Stocks, Financial Services, Healthcare, Technology
Dividends
| Dividend Yield | 1.89% |
| Yield on Cost 5y | 3.11% |
| Yield CAGR 5y | 6.24% |
| Payout Consistency | 96.1% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 11.3% |
| Relative Tail Risk | 1.77% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.71 |
| Alpha | 2.21 |
| Character TTM | |
|---|---|
| Beta | 0.755 |
| Beta Downside | 0.814 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.76% |
| CAGR/Max DD | 0.85 |
Description: IUSV Core S&P U.S. Value December 19, 2025
The iShares Core S&P U.S. Value ETF (IUSV) is designed to track the S&P 500 Value Index, allocating at least 80 % of its net assets to the index’s component securities or securities that are “substantially identical.” The remaining ≤ 20 % may be placed in cash, cash equivalents, or derivative contracts (futures, options, swaps) to manage liquidity, tax efficiency, or tracking error.
Key quantitative metrics (as of Q3 2025):
• Expense ratio ≈ 0.04 % (one of the lowest in the large-value space).
• Assets under management ≈ $5.2 billion, indicating solid investor demand.
• Weighted-average dividend yield ≈ 2.2 % and a price-to-book ratio of ~1.6, both above the S&P 500 average, reflecting the fund’s value tilt.
Primary economic drivers for IUSV’s performance include :
• U.S. interest-rate outlook – higher rates tend to compress growth-oriented (growth) stocks while supporting value-oriented sectors such as financials and industrials.
• Domestic GDP growth – a strengthening economy lifts cyclical value sectors (e.g., consumer discretionary, materials).
• Corporate earnings resilience – value stocks typically have higher cash flows and lower leverage, making them less sensitive to earnings volatility.
Top sector exposures (Q3 2025) are financials (≈ 22 %), industrials (≈ 18 %), and consumer discretionary (≈ 15 %), aligning with the classic value profile.
For a deeper dive into how IUSV fits into a broader value strategy, you might explore the analytics on ValueRay.
What is the price of IUSV shares?
Over the past week, the price has changed by +1.51%, over one month by +2.82%, over three months by +6.87% and over the past year by +15.71%.
Is IUSV a buy, sell or hold?
What are the forecasts/targets for the IUSV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 124.6 | 15.8% |
IUSV Fundamental Data Overview February 07, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 24.19b USD (24.19b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 24.19b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 24.19b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.70% (E(24.19b)/V(24.19b) * Re(8.70%) + (debt-free company))
Discount Rate = 8.70% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)